31 Jul What Is a Standardised Botanical Extract?
A purchase specification that simply states “turmeric extract” or “ginseng extract” leaves too much open to interpretation. For a manufacturer, the relevant question is: what is a standardised botanical extract, and which measurable characteristics will remain consistent from one batch to the next?
A standardised botanical extract is a plant-derived ingredient produced to contain a defined level of one or more specified compounds, often called marker compounds or active constituents. The stated level is verified by an agreed analytical method and expressed on the product specification and Certificate of Analysis (CoA). This gives formulators and procurement teams a clearer basis for calculating inclusion rates, managing label declarations and qualifying replacement batches.
Standardisation is useful, but it is not a universal measure of quality or efficacy. It is one part of a wider raw-material specification that should also cover botanical identity, extraction parameters, physical characteristics, microbiological limits and contaminant controls.
What a standardised botanical extract means in practice
The starting material is a defined botanical species, normally identified by its Latin binomial name and relevant plant part. For example, an extract may be derived from Curcuma longa rhizome, Panax ginseng root or Vaccinium myrtillus fruit. Species and plant part matter because the phytochemical profile can vary significantly across a plant.
The material is then extracted using a controlled process. Water, ethanol and hydroalcoholic systems are common, although the appropriate solvent depends on the target compounds and intended application. The resulting extract is adjusted, concentrated or blended as necessary to meet a specified constituent level.
A label claim such as “green tea extract standardised to 50% polyphenols” means the batch is expected to contain 50% total polyphenols according to the stated method. A more specific example may be “milk thistle extract standardised to 80% silymarin”. In each case, the percentage is meaningful only when the botanical source, analytical method and reporting basis are also clear.
For B2B purchasing, standardisation should be understood as a measurable supply requirement rather than a marketing term. It allows a buyer to procure to an assay specification rather than relying solely on a generic ingredient name.
Standardised botanical extract specifications: the key elements
A sound specification does more than state an assay percentage. It establishes the identity and quality framework for the ingredient being supplied.
Botanical identity and plant part
The specification should identify the botanical by Latin name, common name and plant part. “Grape seed extract” and “grape skin extract”, for instance, are not interchangeable materials, even where both may be associated with polyphenolic compounds. The country of origin and cultivation status may also be commercially relevant, particularly where organic certification or origin-specific sourcing is required.
Authentication may include macroscopic and microscopic examination for raw botanicals, alongside chromatographic fingerprinting, DNA methods where appropriate, or other recognised identity tests. Extracted powders can be more difficult to authenticate than whole herbs, which makes supplier qualification and traceable documentation especially important.
Marker compounds and assay level
Marker compounds are selected constituents used to define or monitor the extract. They may be compounds associated with the botanical’s established use, compounds that support identity testing, or simply practical indicators of manufacturing consistency.
An assay can be expressed as total compounds, such as total flavonoids or total polysaccharides, or as individual compounds, such as curcuminoids, ginsenosides or rosmarinic acid. These approaches are not equivalent. A total-compound assay may provide a broad compositional indication, while an individual-compound assay can offer greater specificity.
The specification should state the assay range rather than only a nominal target. For example, a 95% curcuminoid extract may be specified as not less than 95.0%, subject to the approved analytical method. Buyers should confirm whether the value is reported on an as-is basis, dry basis or another defined basis, as moisture content can affect results.
Extraction ratio and processing information
The drug-extract ratio, often abbreviated as DER, indicates the relationship between the quantity of starting botanical material and the quantity of final extract produced. A 10:1 extract does not automatically have ten times the potency of powdered herb, nor does it confirm the concentration of a particular constituent. It is a process descriptor, not a substitute for an assay.
Processing details can materially affect formulation performance. These include extraction solvent, carrier material, particle size, bulk density, moisture and flow properties. A botanical extract standardised to the same marker level may still behave differently in tablets, capsules, powders or beverage systems if its carrier or physical specification differs.
Analytical methods and reference standards
A percentage without an analytical method has limited procurement value. High-performance liquid chromatography is commonly used for individual marker compounds, while UV-visible spectrophotometry may be used for certain total constituent groups. Gas chromatography, titration and other methods may also be suitable depending on the ingredient.
The method should be appropriate to the stated claim and controlled against suitable reference standards. Where a product specification uses terms such as “total flavonoids”, buyers should establish the calibration standard used. Results expressed as quercetin equivalents, rutin equivalents or another reference can differ and should not be compared without context.
Why standardisation matters to formulation and procurement
Botanical raw materials are naturally variable. Weather, soil conditions, harvest timing, plant genetics, storage and extraction conditions all influence composition. Standardisation helps reduce the effect of that variability on a finished formulation.
For product developers, this supports more reliable active-constituent delivery per serving. If a formula requires 200 mg of curcuminoids, a 95% curcuminoid extract permits a different inclusion calculation from an extract standardised to 20%. This can influence capsule fill weight, serving size, cost in use and the feasibility of a particular dosage format.
For procurement managers, a defined assay and method make it easier to compare like-for-like supplier quotations. A lower price per kilogram is not necessarily a lower cost per unit of marker compound. Comparing cost per kilogram of assay-active material, while accounting for lead time, documentation, origin and freight, gives a more commercially useful picture.
For contract manufacturers, a controlled specification supports incoming-goods checks and batch release. It also reduces the likelihood that an apparently equivalent substitute will alter colour, taste, tablet compression or declared constituent content.
Standardisation does not prove the whole extract is identical
Two extracts can carry the same standardisation claim and still have different wider phytochemical profiles. A botanical contains many compounds, and selecting one marker or a small group of markers does not characterise every constituent present.
This distinction matters when a formulation is designed around a full-spectrum profile rather than a single quantified component. Different solvents, plant origins and processing conditions can preserve or remove compounds beyond the stated marker. For this reason, chromatographic fingerprints and defined manufacturing parameters may be appropriate for higher-specification projects.
Equally, a high assay is not always the best choice. Highly concentrated extracts can introduce formulation constraints, including flavour, hygroscopicity, colour intensity or cost. In some applications, a lower-ratio extract or whole-herb powder may be the more suitable raw material. The correct specification depends on the product concept, target dose, format and claims strategy.
Quality controls beyond the assay
A standardised assay should sit within a full quality-control programme. At minimum, buyers should assess the CoA and product specification against agreed limits for moisture, microbiology, heavy metals, pesticide residues where relevant, residual solvents, mycotoxins and other botanical-specific contaminants.
Adulteration risk also needs consideration. Some high-value botanicals are vulnerable to substitution, dilution or the addition of undeclared compounds. Identity testing, supply-chain traceability, risk-based testing plans and documented supplier approval are essential controls, particularly for ingredients used across multiple finished-product batches.
Organic and conventional grades require separate attention. An organic botanical extract must meet the applicable certification and traceability requirements throughout the relevant supply chain. Organic status does not replace the need for assay, identity and contaminant specifications, and a conventional extract should not be treated as equivalent merely because it has the same marker percentage.
Questions to ask before buying a standardised extract
Before approving a material, buyers should confirm the Latin name and plant part, assay target and acceptance range, analytical method, extraction solvent, carrier system and relevant physical properties. They should also establish whether the quoted price relates to the same assay level, origin and documentation package as the alternative being assessed.
Requesting recent CoAs is useful, but one result should not be treated as proof of long-term consistency. Review batch history where available and agree how specification changes, source changes or test-method changes will be communicated. This is particularly relevant for brands supplying regulated markets or managing tight finished-product tolerances.
Nutra Ingredients supports trade buyers with botanical extracts and wider nutraceutical raw materials selected for formulation and procurement requirements. The most effective sourcing discussions begin with a complete specification, rather than an ingredient name alone.
A standardised extract becomes genuinely valuable when the specification can be translated directly into a finished-product requirement: the right botanical, the right constituent level, the right test method and the right controls for repeatable supply.

